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of an arterial embolus.3,4 Other diagnoses of PDE may be
considered presumptive if the following criteria are ful-
filled: (1) systemic arterial embolus in the absence of left-
sided cardiac or proximal arterial source; (2) a right-to-left
shunt at some level; (3) venous thrombosis and/or pul-
monary embolus. The diagnosis of PDE is termed possi-
ble only if arterial embolus and PFO are detected.4
This retrospective review describes a single center’s
experience with 13 patients fulfilling the criteria for pre-
sumptive PDE. In addition to the clinical presentation and
methods of diagnosis, specific areas of interest included
the early and late results of treatment.
PATIENTS AND METHODS
From October 1989 until November 1999, 3429
patients had a discharge diagnosis of venous thromboem-
bolism and 2764 had a discharge diagnosis of arterial occlu-
sion at our center. A retrospective chart review of all
patients with the discharge diagnosis of venous throm-
boembolism and arterial embolus (27 patients) or patent
foramen ovale (PFO) and arterial embolus (24 patients) was
conducted. Only patients with simultaneous deep venous
thrombosis (DVT) or pulmonary embolus (PE), arterial
embolus, and PFO were considered to have presumptive
PDE. Patient management, morbidity, mortality, and fol-
low-up events were recorded. Follow-up events were deter-
mined from office chart review and telephone survey.
Paradoxical embolism (PDE) describes the passage of
venous or right-sided cardiac thrombus into the arterial or
systemic circulation. This occurs most commonly through
an intracardiac defect at the atrial level.1 First reported by
Cohnhein in 1877,2 PDE was once believed to account
for few acute arterial occlusions. Recent reports, however,
have suggested that PDE could account for as many as
47,000 unexplained ischemic strokes in young patients
each year.3 These divergent views regarding the incidence
of PDE may reflect the varied criteria used to establish the
diagnosis.
The diagnosis of PDE has been termed definitive
when made at autopsy or when thrombus is seen crossing
an intracardiac defect during echocardiography in the face
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Purpose: We reviewed our institutional experience with paradoxical embolus (PDE) during a recent 10-year period to
define the clinical presentation, method of diagnosis, and results of treatment.
Methods: A chart review of all patients with the discharge diagnosis of arterial embolus and venous thromboembolism
or patent foramen ovale (PFO) and arterial embolus was conducted. Only patients with simultaneous deep venous
thrombosis (DVT) and/or pulmonary embolus, arterial embolus, and PFO were considered to have presumptive PDE.
Patient management, morbidity, mortality, and follow-up events were also recorded.
Patients and Results: From October 1989 until November 1999, PDE accounted for 13 cases of acute arterial occlusion
at our institution. There were seven men and six women (mean age, 57 ± 11 years). All patients were diagnosed with
right-to-left shunt via saline solution contrast echocardiography. Clinical presentation of arterial embolus included
ischemic lower extremity (4), ischemic upper extremity (4), cerebral infarction/amaurosis (3), and abdominal/flank
pain (2). Five patients also presented with concomitant respiratory distress. Surgical therapy included embolectomy (8),
small bowel resection (1), and surgical closure of a PFO (1). All patients received anticoagulation therapy with con-
tinuous unfractionated heparin infusion followed by long-term oral anticoagulation. Five inferior vena caval filters were
placed.
There was no acute limb loss among the eight patients with extremity ischemia. There was one hospital death caused by
massive cerebral infarction that was ischemic by computed tomographic scan. Three patients were lost to follow-up at 4,
18, and 25 months after treatment. Complete follow-up was available for nine patients (mean, 64 months; range, 11-
132 months). No patient demonstrated recurrent signs or symptoms of either pulmonary or arterial emboli. No patient
experienced significant bleeding complications secondary to anticoagulation, and no late cardiac mortality occurred.
Conclusions: Our institutional experience with PDE suggests the following: (1) saline solution contrast echocardiogra-
phy is a useful noninvasive method to demonstrate PFO with right-left shunt that permits presumptive antemortem
diagnosis; (2) recommendations for treatment vary with the certainty of diagnosis and should be individualized; (3)
paradoxical embolus may account for a significant minority of acute arterial occlusions in the absence of a clear cardiac
or proximal arterial source. (J Vasc Surg 2001;34:860-5.)
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During the study period, PDE accounted for 13 cases
of acute arterial occlusion at our institution. Patient demo-
graphics, presenting signs and symptoms, and treatment
are summarized in the Table. All patients were diagnosed
with PFO by contrast (saline solution agitation), transtho-
racic, or transesophageal echocardiography with docu-
mented right-to-left shunt at rest or with provocative
maneuvers. A test was considered positive when two to five
micro bubbles crossed the interatrial septum within three
cycles of complete opacification of the right atrium (Fig 1).
Pulmonary embolism was diagnosed by ventilation-
perfusion lung scan, pulmonary arteriogram, or spiral
computed tomography (CT). DVT was diagnosed via
venous duplex sonography.
There were seven men and six women (mean age, 57
± 11 years) diagnosed with PDE. Clinical presentation
included ischemic upper extremity (4), ischemic lower
extremity (4), cerebral infarction/amaurosis (3), abdomi-
nal/flank pain (2). All three patients with cerebral symp-
toms had negative carotid duplex examinations. Five
patients also presented with concomitant respiratory dis-
tress (Fig 2A).
DVT and/or PE was diagnosed at the time of arterial
embolization in all patients. PE was documented in seven
patients by pulmonary angiogram (3), high probability
ventilation-perfusion scan (3), or spiral CT scan (1) (Fig
2B). DVT was detected via venous duplex in eight
patients. A right atrial thrombus was detected on echocar-
diography in one patient.
Surgical embolectomy was performed for each of the
eight patients presenting with limb-threatening ischemia.
Two patients had visceral or renal artery emboli both pre-
senting with abdominal pain. One presented with peri-
tonitis and underwent resection of ischemic bowel at a
referring institution. Subsequent aortography demon-
strated embolic occlusion of the superior mesenteric
artery. The second patient with abdominal and flank pain
had a right renal infarct demonstrated via abdominal CT
scan and renal artery occlusion confirmed with renal
duplex sonography. Neither patient underwent further
surgical intervention. One patient had surgical closure of
his PFO in combination with right atrial thrombectomy.
On presentation, all patients received systemic antico-
agulation by continuous infusion of unfractionated
heparin followed by chronic Coumadin therapy. In addi-
tion, five patients had inferior vena caval filters placed. All
filters were placed below the renal veins. No patient had
an identifiable coagulation disorder.
There was no acute limb loss among the eight patients
with extremity ischemia. There was one hospital death
caused by massive cerebral infarction that was ischemic by
CT scan. Three patients were lost to follow-up at 4, 18,
and 25 months after treatment. Complete follow-up was
Fig 1. Echocardiogram demonstrating a positive saline solution
agitation study with micro bubbles seen in the left atrium (LA)
after complete opacification of right atrium (RA).
Fig 2. A, Arteriogram demonstrating bilateral filling defects in the
popliteal arteries consistent with embolic occlusions. B, Pulmonary
arteriogram in the same patient demonstrating large pulmonary
embolus. Contrast echocardiography demonstrated a PFO with
right-to-left shunt.
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available for nine patients (mean, 64 months; range, 11-
132 months). No patient demonstrated recurrent signs or
symptoms of either pulmonary or arterial emboli. No
patient had significant bleeding complications secondary
to anticoagulation, and no late cardiac mortality occurred.
DISCUSSION
Although widely considered an uncommon cause of
acute arterial occlusion, PDE should be considered in all
patients with an arterial embolus in the absence of a car-
diac or proximal arterial source. In this review, we present
13 patients who met presumptive criteria for PDE. All
patients presented with simultaneous DVT and/or PE,
arterial embolus, and a PFO with right-to-left shunt. All
patients were treated with early intravenous anticoagula-
tion and maintained on long-term oral anticoagulation.
Vena caval filters were placed selectively. No patient expe-
rienced a recurrent pulmonary or systemic embolic event.
Although small in absolute number of patients and likely
an underestimation of the true incidence of PDE, this
review describes the largest single-center experience for
presumptive PDE.
Data regarding the true contribution of PDE to acute
arterial occlusions are incomplete; however, the presence
of a PFO cannot be viewed as equivalent to that of PDE.
Autopsy studies have described a 25% to 30% incidence of
PFO.6,7 Saline solution agitation echocardiography has
suggested that 5% to 15% of “normal” patients have PFO
associated with a right-to-left shunt.3,8 However, only
when clot is seen traversing a PFO on echocardiography
can the antemortem diagnosis of PDE be considered the
definitive cause of an acute arterial occlusion.3,4 Other
cases may be considered presumptive and can be treated
with confidence when the three criteria of DVT and/or
PE, arterial embolus, and PFO with right-to-left shunt are
present in a single patient.3-5 When concomitant DVT
and/or PE is not present, the diagnosis of PDE based on
an arterial embolus associated with PFO can, at best, be
termed possible.5 Consequently, reported results from
recommended treatment must be considered in the con-
text of the certainty of diagnosis—definitive, presumptive,
or possible.
Recommended treatment to prevent recurrent arterial
emboli after PDE have included observation, antiplatelet
agents, systemic anticoagulation, and closure of the
PFO.9-11 However, the clinical course of patients with
definitive or presumptive PDE is unknown. Bogousslovsky
et al9 reported 140 patients with PFO and either stroke or
transient ischemic attack (TIA) treated with aspirin (66%),
Coumadin (26%), or closure of PFO (8%) with a mean fol-
low-up 3 years (10-91 months). Only 11 of 140 patients
had a history of DVT or PE. Therefore, in 92% of patients,
the diagnosis was only possible. Recurrence of stroke or
TIA was 3.8% per year. Method of treatment was not a
predictor of recurrence. Mas et al10 described 132 patients
with cerebrovascular symptoms and PFO. No patient was
diagnosed with concomitant DVT or PE. All patients were
treated with Coumadin or aspirin. Mean follow-up was
22.6 months, and risk of recurrent cerebrovascular symp-
toms was 3.4% per year. Although both of these series
describe large numbers of patients, the diagnosis of PDE
was possible and therefore uncertain in the vast majority.
Consequently, it is difficult to draw conclusions regarding
the effectiveness of the proposed treatment.
In addition to antiplatelet agents and systemic antico-
agulation, PFO closure has been recommended in selected
patients with PDE. Closure can be accomplished via per-
cutaneous or open surgical methods. Hung et al12 pre-
sented 63 patients averaging 46 years of age with PFO and
neurologic symptoms thought to be secondary to PDE.
Case summaries (n = 13)
Site of embolus
IVC Chronic
Age (y) Sex Presentation DVT Pulmonary Peripheral Embolectomy filter anticoagulation
68 M Abdominal pain Y N Renal N Y Y*
51 M Amaurosis/dyspnea Y Y Cerebral N Y Y†
65 F Ischemic leg/dyspnea N Y Popliteal Y N Y†
49 F Ischemic arm N Y Brachial Y Y Y*
43 M Abdominal pain Y Y SMA N Y Y*
42 F Ischemic leg/dyspnea Y Y Femoral Y N Y†
63 M CVA Y N Cerebral N Y N‡
50 M CVA N§ N§ Cerebral N N Y†
63 M Ischemic arm/dyspnea N Y Brachial Y N Y†
48 F Ischemic leg Y N Femoral Y N Y†
79 F Ischemic leg Y N Femoral Y N Y†
69 M Ischemic arm/dyspnea N Y Subclavian Y N Y†





IVC, inferior vena cava; M, male; F, female; SMA, superior mesenteric artery; CVA, cerebrovascular accident.
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Although each patient underwent percutaneous closure of
his or her cardiac defect, no documentation of concomi-
tant DVT or PE was made, and the diagnosis of PDE was
only possible. After percutaneous treatment, there were
three deaths unrelated to the device placement, but one
patient died of a massive pulmonary embolus. The PFO
was closed or had “minimal” residual shunting in 86% of
patients by echocardiography. The average risk of recur-
rent neurologic symptoms was 3.2% per year after percu-
taneous intervention.12 In another recent report,
Windecker et al13 described 80 patients who had percuta-
neous closure of their PFO for “suspected” PDE. No
patient had a diagnosis of concomitant DVT or PE. There
was no periprocedural mortality, but a 10% procedural
morbidity was observed that included embolization of
device (3), cerebrovascular accident (1), cardiac tampon-
ade (1), air embolus (2), and a hematoma requiring surgi-
cal intervention (1). The average risk of recurrence of
neurologic symptoms was 3.4% per year with a mean fol-
low-up of 1.6 ± 1.4 years.13
Open surgical methods have been used to close PFO
and prevent recurrent systemic emboli. In the largest series
to date, Dearani et al14 reported 91 patients with stroke or
TIA who underwent open surgical closure of PFO. Only
nine patients had documented DVT or PE. There was no
30-day mortality; however, 20% of patients had significant
periprocedural morbidity. The PFO was successfully closed
on repeat postoperative echocardiography in all patients,
and 54% of patients were maintained on chronic Coumadin
anticoagulation. Despite this, there were eight recurrent
neurologic events on mean follow-up of 2 years, providing
an average risk of four embolic events per year.14
Recurrence of cerebrovascular events after medical
treatment of PDE may reflect failure of treatment or failure
of diagnosis. However, recurrent cerebral events after suc-
cessful closure of PFO for possible PDE almost certainly
reflects failure of diagnosis. These considerations are perti-
nent considering the perceived role of PFO in young
patients with cryptogenic strokes.10-17 Although PDE may
be an attractive explanation for cerebral events in this
group, the true cause and effect of a PFO and stroke is
uncertain.9-18 In our retrospective series of 13 patients with
presumptive PDE, the most common site of arterial embo-
lus was the extremities, not the cerebral circulation. This is
consistent with other peripheral arterial emboli from cardiac
sources.4 Moreover, in a review of 30 definitive cases of
PDE when clot was visualized traversing a PFO on an
echocardiogram, only 28% of arterial emboli involved the
cerebral circulation, whereas 28% involved the peripheral
circulation and 38% reached the mesenteric vessels.3
In patients with suspected PDE, evaluation should
include contrast echocardiography. The transesophageal
approach is preferable because it more accurately demon-
strates cardiac pathophysiology. It readily demonstrates
right-to-left shunts at the atrial level and has a sensitivity
and specificity of almost 95%.19 The development of this
technique has allowed more frequent antemortem diagno-
sis without the use of invasive procedures.3,19 After estab-
lishing an intracardiac defect with a right-to-left shunt, a
venous evaluation for the presence of DVT is performed.
Both upper-extremity and lower-extremity venous duplex
sonography should be performed in all patients evaluated
for PDE. Ventilation-perfusion lung scans, spiral CT
scans, or pulmonary angiography may be used in patients
with symptoms of concomitant pulmonary embolism. An
evaluation for a procoagulant disorder may guide the
duration of anticoagulation.
Based on our experience and the available literature,
we have adopted the following strategy for the diagnosis
and management of PDE. Using clinical and pathologic
criteria, a presumptive diagnosis can be made with demon-
stration of a right-to-left shunt, concomitant DVT and/or
pulmonary embolism, and systemic arterial embolization.
If a clot is not visualized traversing a PFO, the diagnosis
involves varying degrees of likelihood and omission of any
of the three presumptive criteria, specifically DVT and/or
PE, increases the uncertainty of the diagnosis. Systemic
anticoagulation is used as the mainstay of therapy for pre-
sumptive PDE, providing treatment and prophylaxis for
DVT, PE, and arterial embolism in the majority of
patients. Continuous intravenous unfractionated heparin
followed by chronic oral anticoagulation is routine. The
duration of anticoagulation therapy is individualized.
Patients with an identifiable but finite risk for DVT (eg,
extremity fracture with cast immobilization) receive 6 to
12 months of oral anticoagulation. Patients who remain at
risk for venous thrombosis (eg, a procoagulant disorder)
and patients who have experienced repeated venous
thrombosis and/or pulmonary embolism may require life-
long therapy.
Inferior vena caval interruption is not considered pri-
mary therapy for PDE because small (<3 mm) emboli that
may be asymptomatic as pulmonary emboli may con-
tribute to catastrophic arterial occlusion in the systemic
circulation. Commonly accepted guidelines are applied to
determine whether inferior vena cava filter placement is
necessary in conjunction with PDE.20 In particular, vena
cava filters appear indicated as primary therapy in patients
who have a contraindication for anticoagulation.20
Inferior vena cava ligation is an effective immediate treat-
ment for PDE of lower-extremity origin; however, opera-
tive and postoperative morbidity are significant.21 In
addition, the inevitable development of collateral venous
circulation with subsequent embolization argues against
the use of vena cava ligation for PDE.21
The decision to close an intracardiac defect should also
be individualized. The risk of the procedure must be com-
pared with the certainty of diagnosis and the probability
that closure will prevent the recurrence of PDE. Only
when all three conditions for presumptive PDE are present
are invasive procedures recommended. However, closure
of a PFO does not treat venous thromboembolic disease.
Closure of a PFO by open or percutaneous methods with
inferior vena cava interruption is recommended in patients
with presumptive PDE who have contraindications to sys-
temic anticoagulation.
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These treatment recommendations can be considered
general guidelines at best. No data exist which accurately
define the incidence or natural history of PDE. The man-
agement strategy employed for this patient group must
emphasize the certainty of diagnosis. With increasing
awareness and evaluation for PDE, future studies may
accurately estimate the incidence of PDE in acute arterial
occlusions. Studies that describe the natural history and
risk of repeated embolization will provide the rationale for
future treatment recommendations.
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Dr Peter Gloviczki (Rochester, Minn). I was asked to discuss
the paper and I enjoyed very much this presentation. I also had a
chance to review the manuscript which is a very well written man-
uscript and I am sure it will be accepted for publication.
Paradoxical embolus is a rare cause of acute ischemia but
really not as rare as I think we all think. In a busy vascular prac-
tice, as you have heard, you will see at least one patient every year
and maybe it is only the tip of the iceberg because there may be
more patients with this type of etiology of embolism. The diag-
nosis is based on high index of suspicion, although in some of the
typical patients, the presentation can be quite dramatic because
the patient may be symptomatic in both the arterial and the
venous bed, or because in some of the patients multiple arterial
beds are affected at the same time.
I remember very well the very first patient that I saw with an
acute ischemia due to paradoxical embolism, and I was an intern.
It was a patient I was asked to see because of acute chest pain,
shortness of breath. The patient developed within minutes an
ischemic right arm and a couple of minutes later died of a massive
stroke. The autopsy revealed iliofemoral DVT with a large PFO.
That leads to my first question of the paper: is the high inci-
dence of strokes in these patients, probably we see much more
frequently than what we see in our patients who present with nor-
mal cardiac embolism? Do you have maybe an explanation why
patients who have a PFO have much higher incidence of stroke
than only those patients who have a thrombus in the atrium or
the ventricle and have peripheral embolization, because otherwise
the most frequent site of peripheral embolism is the femoral bifur-
cation?
My second question again comes back to the indication of
closure of the PFO and the need for a Greenfield filter. If that
patient has a high PFO with a documented shunt, can we still just
stick to the classic indications of IVC filter placement or should
we be a little bit more liberal and place a filter in that patient
because of the serious consequences of arterial embolism?
Finally, you mentioned the technique of cardiac echo. Should
we get in these patients routinely transesophageal echo especially
those who have chest pain and you are looking for other etiolo-
gies of embolism like aortic dissection? Should we routinely get
cardiac echo in these patients before we deal with the ischemic
limb or the ischemic symptoms of the patients?
I enjoyed very much your presentation and congratulate you
on the paper.
Dr Jeffrey A. Travis. Your first question is why patients with
PFO seem to have an increased incidence of stroke. I am not sure
a true cause and effect actually exist. Certainly many people have
strokes and many are termed cryptogenic when no specific cause
is identified. In young patients, a higher incidence of PFO than in
the general population has been identified, but I do not think we
can draw a true cause and effect relationship just based on that.
There is an epidemiological study from Sweden that identified
new strokes in patients aged 18 to 44 years. Over a 3-year period,
there were 88 new strokes. This was from a population base of
approximately 500,000. In half of these, no cause could be iden-
DISCUSSION
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tified; however, in only 10% of those did the patient have a PFO.
So there are certainly causes of cerebral symptoms in young
patients that are not due to paradoxical embolus even in patients
who have a PFO.
Your second question about who should have an inferior
vena cava filter placed. We do not believe that inferior vena cava
filters completely protect someone from a paradoxical embolus.
They can admit emboli as small as 3 mm, which are clinically
silent in the pulmonary circulation but can be devastating when
placed in the arterial circulation.
Who should we perform TEE on? The test does not need to
be performed prior to the operating room to do an embolectomy
because often the extremity ischemia is a more pressing issue and in
many centers echo is not immediately available. In any patient with
a cryptogenic embolic event, a transesophageal echo is indicated.
Dr John Ricotta (Stony Brook, NY). A comment and a ques-
tion. The comment is that sometimes thrombolytic therapy can
be effective in these patients. We actually had a patient that we
have given thrombolysis because of a pulmonary embolus and,
because of the systemic lytic effects, seen the arterial embolus go
away. Obviously you cannot use that if the arterial embolus is pro-
ducing acute ischemia, but if you have a situation where the limb
is viable, that actually is an option.
The second point, I would like to expand on what Dr Gloviczki
said. It seems to me that one of the keys here is whether the patient
has pulmonary hypertension. Usually they get a pulmonary embo-
lus, they get pulmonary hypertension, then the foramen ovale opens
and they get an embolus. I again would feel very uncomfortable not
putting a filter in somebody that you were pretty sure had a para-
doxical embolus, particularly if they had pulmonary hypertension. I
wondered whether you would comment on that as possibly a way to
broaden your indications for filter placement.
Dr Travis. In a patient who has had a previous pulmonary
embolus, they present with a paradoxical embolus, should that
patient receive an IVC filter?
Dr Ricotta. Right.
Dr Travis. We believe that anticoagulation still maintains its
role as the mainstay of therapy. If you prevent venous throm-
boembolism, then you prevent paradoxical embolus.
Dr Gloviczki. Have you had any of your patients develop
paradoxical embolus on anticoagulation?
Dr Travis. No, sir, not in our experience.
Dr Gloviczki. Dr Greenfield, should we use the filter more
liberally in these patients? 
Dr Lazar Greenfield (Ann Arbor, Mich). I think a significant
part of the problem has not been addressed, and that is the pul-
monary hypertension. That is a major driver of the right-to-left
shunt, and you did not mention information in your series about
the level of pulmonary artery pressure in your patients. What you
are also obligated to treat is the level of pulmonary vascular
reserve, and I guess the question is, are you satisfied in a patient
with serious elevation of pulmonary artery pressures to manage
that patient’s venous thrombotic disease with anticoagulation
alone, recognizing that even a small recurrent pulmonary embolic
event could be just as disastrous as a paradoxical embolus?
Dr Travis. We do not have the information on all patients and
their pulmonary artery pressures and whether or not they had
pulmonary hypertension. I can tell you that none of these patients
had a history of previous pulmonary embolus. Many of the
patients require provocative maneuvers to demonstrate a right-to-
left shunt. In other words, you have to have them Valsalva or
cough. This is a well-known presentation of paradoxical embolus
in a patient who is straining to defecate or coughing, and then has
an acute arterial embolus, but I do not have the discrete infor-
mation on all their pulmonary artery pressures.
Dr Alan Dardik (Baltimore, Md). Two quick questions. First,
how did you determine your study population? Was it by ICD-9
coding and review of the database? Because you quoted to us a
10% incidence of PFO and if you queried over 2700 patients, you
should have gotten over 200 patients with PFOs. Are you under-
coding your database and thereby underestimating the incidence
of this problem? This leads me to the second question, if we are
going to design a prospective study, who should we be screening
for PFO?
Dr Travis. In regards to the first question, yes, I think this is
obviously an underestimation of this problem, but by applying
strict criteria to the diagnosis I think we can better evaluate our
treatment efficacy.
As far as the second question, who should we screen? I think
any patient with cryptogenic arterial emboli with an unknown
cause. DVT is undetected in 50% of people with proven pul-
monary embolism; therefore, it is difficult to detect. Therefore,
anybody with an unexplained arterial event should probably be
screened for PFO and possible paradoxical embolus.
